Overview This page contains the latest trade data of Heterocyclic compounds containing a phenothiazine rin. In 2023, Heterocyclic compounds containing a phenothiazine rin were the world's 4018th most traded product, with a total trade of $108M. Between 2022 and 2023 the exports of Heterocyclic compounds containing a phenothiazine rin decreased by -9%, from $119M to $108M. Trade in Heterocyclic compounds containing a phenothiazine rin represent 0.00048% of total world trade.
Heterocyclic compounds containing a phenothiazine rin are a part of Nucleic Acids.
Exports In 2023 the top exporters of Heterocyclic compounds containing a phenothiazine rin were France ($23.2M), Germany ($17.8M), India ($15M), United States ($9.78M), and China ($9.33M).
Imports In 2023 the top importers of Heterocyclic compounds containing a phenothiazine rin were Brazil ($15.1M), France ($13.2M), United States ($9.19M), India ($7.58M), and China ($6.11M).
Ranking Heterocyclic compounds containing a phenothiazine rin ranks 839th in the Product Complexity Index (PCI).
Description Phenothiazine drugs are used in the treatment of various types of mental illnesses (e.g., schizophrenia) and have side effects such as drowsiness, dizziness, skin rash, weight gain, hair loss, and vision problems.